Ventilator-Associated Pneumonia: Revisited


Affiliations

  • Punjab Institute of Medical Sciences, Department of Anaesthesia and Intensive Care, Jalandhar, Punjab, India
  • Department of Anaesthesia and Intensive Care, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India

Abstract

Ventilator-associated pneumonia (VAP) is a type of hospital acquired pneumonia commonly encountered in patients who receive mechanical ventilation and is associated with significant mortality and morbidity. VAP is associated with prolonged ventilation, increased antibiotic use, emergence of multidrug resistant organisms, prolonged critical care unit stay resulting in increased cost of care. It has been reported to occur in 9 to27 percent of all intubated patients. As per International Nosocomial Infection Control Consortium (INICC) report data summary, the overall rate of VAP was 13.6 per 1,000 ventilator days. Preventive measures, early diagnosis and treatment of VAP result in better outcome. The aim of this review was to search the literature for incidence, various risk factors, etiology, pathogenesis, treatment, and prevention of VAP. A literature search for VAP was done through the PUBMED/MEDLINE database. VAP is a commonly encountered nosocomial infection occurring in ventilated patients and is associated with increased mortality and morbidity. Outcome of patient with VAP depends on hospital setting, patient group, infection control policy, early diagnosis and judicious antibiotic use.

Keywords

Ventilator-Associated Pneumonia, Mechanical Ventilation, Prevention.

Subject Discipline

Health Care and Hospital Management

Full Text:

References

Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilatorassociated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249-56.

American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.

Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez, et al. International Nosocomial Infection Control Consortium(INICC) report, data summary for 2003-2008, issued june 2009. Am J Infect Control 2010;38:95104.

DY Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India: incidence and risk factors. J Infect Dev Ctries 2009;3:771–7.

Choudhuri AH. Ventilator-Associated Pneumonia: When to hold the breath? Int J Crit Illn Inj Sci 2013;3:169–74.

Chastre J, Fagon JY. Ventilatorassociated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.

Hunter JD. Effects of anaesthesia on the human immune system. Hosp Med 1999;60:658–63.

Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora in hospitalized patients: Emergence of gram-negative bacilli. N Engl J Med 1969;281:1137–40.

Bahrani-Mougeot FK, Paster BJ, Coleman S, Barbuto S, Brennan MT, Noll J, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol 2007;45:1588–93.

Cook DJ,Kollef MH.Risk factors for ICUacquired pneumonia. JAMA 1998; 279:1605-6.

Kollef MH. Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. Clin Chest Med 1999;20:653–70.

Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433–40.

Hunter JD. Ventilator associated pneumonia. BMJ 2012;344:e3325.

Fà bregas N, Ewig R, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP, Bauer T, Cabello H. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54:867–73.

Wunderink RG. Clinical criteria in the diagnosis of ventilator-associated pneumonia. Chest 2000;117:191S–4S.

Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121–9.

Pugin J. Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol 2002;68:261–5.

Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, Bollet C, Fuentes P, Gouin F. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995;152:1982–91.

Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004;350:451–8.

Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011;27:149-62.

Torres A, Ewig S, Lode H, Carlet J. Defining,treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009;35:798-816.

Dimopoulos G, Poulakou IA, Armaganidis A, Kollef MH, Matthaiou DK. Short versus long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013;144:1759-67.

Park DR. Antimicrobial treatment of ventilator-associated pneumonia. Respir Care 2005;50:932–52.

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–85.

American Thoracic Society. Hospitalacquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996;153:1711–25.

Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gramnegative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003;31:1908–14.

Adair CG, Gorman SP, Byers LM, Jones DS, Feron B, Crowe M, Webb HC, McCarthy GJ, Milligan KR. Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med 2002;28:426–31.

Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APICIDSA Hand Hygiene Task Force. Am J Infect Control 2002;30:S1–S46.

Bloos F, Muller S, Harz A, Gugel M, Geil D, Egerland K, et al. Effects of staff training on the care of mechanically ventilated patients: a prospective cohort study. Br J Anaesth 2009;103:232–7.

Salahuddin N, Zafar A, Sukhyani L, Rahim S, Noor MF, Hussain K, et al. Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infect 2004;57:223–7.

Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia? A survey based on the opinions of an international panel of intensivists. Chest 2002;122:656–61.

Ricart M, Lorente C, Diaz E, Kollef MH, Rello J. Nursing adherence with evidence-based guidelines for

preventing ventilator-associated pneumonia. Crit Care Med 2003;31:2693–96.

Hess DR. Noninvasive positive-pressure ventilation and ventilator-associated pneumonia. Respir Care 2005;50:924– 9.discussion 929-31.

Antonelli M, Conti G, Rocco M, Bufi M, De Blasi RA, Vivino G, et al. A comparison of noninvasive positivepressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998;339:429–35.

Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999;27:2609–15.

Ely EW, Meade MO, Haponik EF, Kollef MH, Cook DJ, Guyatt GH, et al. Mechanical ventilator weaning

protocols driven by nonphysician health-care professionals: Evidencebased clinical practice guidelines. Chest 2001;120:454S–63S.

Torres A, Gatell JM, Aznar E, el-Ebiary M, Puig de la Bellacasa J, Gonzalez J, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995;152:137–41.

Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 2002;346:1715– 22.

Özçaka Ö, Başoğlu OK, Buduneli N, Tasbakan MS, Bacakoglu F, Kinane DF. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodontal Res 2012;47:584–92.

Lambeau SO, Van de Vyver K, Brusselaers N, Vogelaers D, Blot Sl. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect Dis 2011;11:845–54.

Andrews T, Steen C. A review of oral preventative strategies to reduce ventilator-associated pneumonia. Nurs Crit Care 2013;18:116–22.

Li J, Xie D, Li A, Yue J. Oral topical decontamination for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Hosp Infect 2013;84:283–93.

Tantipong H, Morkchareonpong C, Jaiyindee S, THamlikitkul V. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infec Control Hosp Epidemiol 2008;29:131–6.

Koeman M, van der Ven AJ, Hak E, Joor HC, Kaasjager K, de Smet AG, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilatorassociated pneumonia. Am J Respir Crit Care Med 2006;173:1348–55.

Kollef MH, Pittet D, Sanchez Garcia M, Chastre J, Fagon JY, Bonten M, et al. A randomized double-blind trial of iseganan in prevention of ventilatorassociated pneumonia. Am J Respir Crit Care Med 2006;173:91–7.

Seguin P, Tanguy M, Laviolle B, Tirel O, Malledant Y. Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma. Crit Care Med 2006;34:1514–9.

de Smet AM, Bonten MJ. Selective decontamination of the digestive tract. Curr Opin Infect Dis 2008;21:179–83.

Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect 2007;65:187–203.

De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20–31.

Oostdijk EA, de Smet AM, Blok HE, Thieme Groen ES, van Asselt GJ, Benus RF, et al. Ecological effects of selective decontamination on resistant gramnegative bacterial colonization. Am J Respir Crit Care Med 2010;181:452–7.

Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilatorassociated pneumonia: a blinded,

randomized, controlled trial. Am J Respir Crit Care Med 2010;182:1058–64.

Orozco-Levi M, Torres A, Ferrer M, Piera C, el-Ebiary M, de la Bellacasa JP, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 1995;152:1387–90.

Torres A, Serra-Batlles J, Rose E, Piera C, Puig de la Bellacasa J, Cosbos A, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position.

Ann Intern Med 1992;116:540–3.

Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mehcnically ventilated patients: a randomized trial. Lancet 1999;354:1851–8.

Muscedere J, Rewa O, McKechnie K, Jiang X, Laporta D, Heyland DK. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis. Crit Care Med

;39:1985–9.

Wang F, Bo L, Tang L, Lou J, Wu Y, Chen F, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: an updated meta-analysis of randomized controlled trials. J Trauma Acute Care Surg 2012;72:1276– 85.

Berra L, De Marchi L, Yu ZX, Laguerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs and endotracheal tube. Anesthesiology 2004;100:1446–56.

Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, et al. Silver-coated endotracheal tubes and the incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300:805–13.

Shorr AF, Zilberberg MD, Kollef M. Costeffectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2009;30:759–63.

Chaiban G, Hanna H, Dvorak T, Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J Antimicrob Chemother 2005;55:51–6.


Refbacks

  • There are currently no refbacks.